228 related articles for article (PubMed ID: 30115016)
1. Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
Sun X; Ju T; Cummings RD
BMC Cancer; 2018 Aug; 18(1):827. PubMed ID: 30115016
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29.
Yu X; Du Z; Sun X; Shi C; Zhang H; Hu T
Int J Clin Exp Pathol; 2015; 8(3):2590-602. PubMed ID: 26045765
[TBL] [Abstract][Full Text] [Related]
3. Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer.
Jiang Y; Liu Z; Xu F; Dong X; Cheng Y; Hu Y; Gao T; Liu J; Yang L; Jia X; Qian H; Wen T; An G
J Cell Mol Med; 2018 Oct; 22(10):4875-4885. PubMed ID: 29999571
[TBL] [Abstract][Full Text] [Related]
4. CD3/CD28 dynabeads induce expression of tn antigen in human t cells accompanied by hypermethylation of the cosmc promoter.
Shi C; Xu X; Yu X; Du Z; Luan X; Liu D; Hu T
Mol Immunol; 2017 Oct; 90():98-105. PubMed ID: 28708980
[TBL] [Abstract][Full Text] [Related]
5. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
6. Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc.
Ju T; Lanneau GS; Gautam T; Wang Y; Xia B; Stowell SR; Willard MT; Wang W; Xia JY; Zuna RE; Laszik Z; Benbrook DM; Hanigan MH; Cummings RD
Cancer Res; 2008 Mar; 68(6):1636-46. PubMed ID: 18339842
[TBL] [Abstract][Full Text] [Related]
7. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation.
Liu Z; Liu J; Dong X; Hu X; Jiang Y; Li L; Du T; Yang L; Wen T; An G; Feng G
J Cell Mol Med; 2019 Mar; 23(3):2083-2092. PubMed ID: 30637914
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
Fu C; Zhao H; Wang Y; Cai H; Xiao Y; Zeng Y; Chen H
HLA; 2016 Dec; 88(6):275-286. PubMed ID: 27679419
[TBL] [Abstract][Full Text] [Related]
9. The Cosmc connection to the Tn antigen in cancer.
Ju T; Aryal RP; Kudelka MR; Wang Y; Cummings RD
Cancer Biomark; 2014 Jan; 14(1):63-81. PubMed ID: 24643043
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen.
Mi R; Song L; Wang Y; Ding X; Zeng J; Lehoux S; Aryal RP; Wang J; Crew VK; van Die I; Chapman AB; Cummings RD; Ju T
J Biol Chem; 2012 Nov; 287(49):41523-33. PubMed ID: 23035125
[TBL] [Abstract][Full Text] [Related]
11. The cytokine-cosmc signaling axis upregulates the tumor-associated carbohydrate antigen Tn.
Ho CW; Lin CY; Liaw YW; Chiang HL; Chin YT; Huang RL; Lai HC; Hsu YW; Kuo PJ; Chen CE; Lin HY; Whang-Peng J; Nieh S; Fu E; Liu LF; Hwang J
Oncotarget; 2016 Sep; 7(38):61930-61944. PubMed ID: 27542280
[TBL] [Abstract][Full Text] [Related]
12. Cosmc is an essential chaperone for correct protein O-glycosylation.
Wang Y; Ju T; Ding X; Xia B; Wang W; Xia L; He M; Cummings RD
Proc Natl Acad Sci U S A; 2010 May; 107(20):9228-33. PubMed ID: 20439703
[TBL] [Abstract][Full Text] [Related]
13. O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization.
Jiang Y; Wen T; Yan R; Kim SR; Stowell SR; Wang W; Wang Y; An G; Cummings RD; Ju T
FASEB J; 2020 Sep; 34(9):11786-11801. PubMed ID: 32692906
[TBL] [Abstract][Full Text] [Related]
14. Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn
Hu W; Ding R; Wang M; Huang P; Wei X; Hu X; Hu T
Stem Cell Res Ther; 2023 May; 14(1):145. PubMed ID: 37237420
[TBL] [Abstract][Full Text] [Related]
15. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
[TBL] [Abstract][Full Text] [Related]
16. Cosmc transfection decreases malignant behavior of Tn
Ding R; Hu X; Hu W; Du Z; Huang P; Wang M; Sheng J; Ma Y; Wang A; Luan X; Dong M; Cao Q; Zou Y; Hu T
Aging (Albany NY); 2021 Oct; 13(19):23393-23406. PubMed ID: 34644263
[TBL] [Abstract][Full Text] [Related]
17. Cosmc overexpression enhances malignancies in human colon cancer.
Gao T; Du T; Hu X; Dong X; Li L; Wang Y; Liu J; Liu L; Gu T; Wen T
J Cell Mol Med; 2020 Jan; 24(1):362-370. PubMed ID: 31633299
[TBL] [Abstract][Full Text] [Related]
18. Functional assays for the molecular chaperone cosmc.
Ju T; Cummings RD
Methods Enzymol; 2010; 479():107-22. PubMed ID: 20816162
[TBL] [Abstract][Full Text] [Related]
19. New mutations in C1GALT1C1 in individuals with Tn positive phenotype.
Crew VK; Singleton BK; Green C; Parsons SF; Daniels G; Anstee DJ
Br J Haematol; 2008 Aug; 142(4):657-67. PubMed ID: 18537974
[TBL] [Abstract][Full Text] [Related]
20. Promoters of Human Cosmc and T-synthase Genes Are Similar in Structure, Yet Different in Epigenetic Regulation.
Zeng J; Mi R; Wang Y; Li Y; Lin L; Yao B; Song L; van Die I; Chapman AB; Cummings RD; Jin P; Ju T
J Biol Chem; 2015 Jul; 290(31):19018-33. PubMed ID: 26063800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
